The results showed that TFF2 expression was significantly elevated in the PC group compared to the benign control, and TFF2 demonstrated the best performance in distinguishing pancreatic benign conditions from malignancies, with an AUC of 0.924 (Figure 5D). This evidence concerns the gene TFF2 and cancer.